1. Barton, M. and Yanagisawa, M., Endothelin: 20 years from discovery to therapy, Can. J. Physiol. Pharmacol., 2008, vol. 86, pp. 485–498.
2. Haendler, B., Hechler, U., and Schleuning, W.-D., Molecular cloning of human endothelin (ET) receptors ETA and ETB, J. Cardiovasc. Pharmacol., 1992, vol. 20, pp. 1–4.
3. Davenport, A.P., D’Orleans-Juste, P., Godfraind, Th., Maguire, J.J., Ohlstein, E.H., and Ruffolo, R.R., Endothelin receptors: ETB receptor. IUPHAR Database (IUPHAR-DB.ORG). Last modified on May 23, 2014; accessed on July 19, 2014.
4. Kohan, D.E., Cleland, J.G., Rubin, L.J., Theodorescu, D., and Barton, M., Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?, Life Sci., 2012, vol. 91, pp. 528–539.
5. Katritch, V., Cherezov, V., and Stevens, R.C., Structure-function of the g protein-coupled receptor superfamily, Annu. Rev. Pharmacol. Toxicol., 2013, vol. 53, pp. 531–556.